GIMBHI’s daily mental health update — 4/12/26

🔄 Qualifacts acquires MethodOne to integrate medication-assisted treatment software for SUD providers (GlobeNewswire via National Law Review) — 04/07/26
TL;DR: Behavioral health EHR leader Qualifacts acquired MethodOne’s controlled-medication dispensing software to create a unified platform for opioid treatment programs and SUD providers.

✂️ Alma lays off 45 staffers while working through merger with Spring Health (Behavioral Health Business) — 04/02/26
TL;DR: Therapist platform Alma cut 45 roles mid-merger with Spring Health; sources say layoffs are unrelated to the deal, expected to close Q2 2026.

🧠 CorTec receives FDA Breakthrough Device Designation for Brain Interchange BCI in stroke recovery (GlobeNewswire) — 04/08/26
TL;DR: German neurotech CorTec became the first BCI company globally to earn FDA Breakthrough status for restoring motor function after chronic stroke via bidirectional cortical stimulation.

🤝 Cognito Therapeutics and Ochsner Health launch Brain Health Collaboratory for Alzheimer’s neurotech delivery (Cognito Therapeutics) — 03/25/26
TL;DR: Cognito partnered with Gulf South health system Ochsner to build a real-world care model for its Spectris neurostimulation platform ahead of anticipated 2027 market entry.

💰 BrainsWay invests additional $6M in Neurolief following FDA approval of at-home depression device (GlobeNewswire) — 03/26/26
TL;DR: BrainsWay triggered a $6M milestone investment in Neurolief after FDA PMA for Proliv™Rx, the first at-home neuromodulation therapy for treatment-refractory MDD, with an acquisition option pending.

📊 Digital health startups raked in $4B in Q1 with 12 megadeals driving investment (Fierce Healthcare) — early April 2026
TL;DR: Rock Health’s Q1 2026 report shows digital health’s strongest first quarter since the pandemic, with mental health capturing 3 of 12 megadeals (Talkiatry, Grow Therapy, Cognito).